GlassScriptPhysician profile
Randall L Hall
NPI 1497739023
$4,299.74
in general payments reported to CMS, 2019-2025
36 companies · $531 in 2025
The $531 reported for 2025 was more than what 75% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,023 · 2020: $308 · 2021: $235 · 2022: $533 · 2023: $925 · 2024: $743 · 2025: $531.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,199.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $449.03 | 2019-2025 | Spravato |
| Otsuka America Pharmaceutical, INC. | $416.05 | 2022-2025 | Rexulti, Nuedexta |
| Abbvie INC. | $380.90 | 2021-2023 | |
| Novo Nordisk INC | $369.06 | 2019-2025 | Rybelsus, Ozempic |
| Pfizer INC. | $302.51 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $198.69 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $193.70 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Almatica Pharma LLC | $180.69 | 2023-2025 | Loreev Xr |
| Glaxosmithkline, LLC. | $176.47 | 2019-2025 | Trelegy Ellipta |
| Novartis Pharmaceuticals Corporation | $174.68 | 2019-2025 | |
| Acadia Pharmaceuticals INC | $160.23 | 2021-2025 | Daybue, Nuplazid |
| Corium, LLC | $145.18 | 2023-2025 | Azstarys |
| Lilly USA, LLC | $141.13 | 2019-2024 | Jardiance |
| Neos Therapeutics, LP | $119.89 | 2023-2024 | Adzenys Xr-Odt |
| Bayer Healthcare Pharmaceuticals INC. | $118.58 | 2022-2024 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $115.34 | 2019 | |
| Exact Sciences Corporation | $93.83 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Avanir Pharmaceuticals, INC. | $75.84 | 2019-2022 | |
| Tris Pharma INC | $50.87 | 2023 | Dyanavel Xr |
| Allergan, INC. | $50.26 | 2020 | |
| Amgen INC. | $47.00 | 2022-2025 | Repatha |
| Lundbeck LLC | $37.13 | 2024-2025 | Rexulti |
| Abbott Laboratories | $36.78 | 2023 | Freestyle Libre 2 |
| Idorsia Pharmaceuticals US INC | $35.10 | 2023 | Quviviq |
| Axsome Therapeutics, INC. | $29.93 | 2025 | Auvelity |
| Shire North American Group INC | $29.92 | 2019 | |
| Supernus Pharmaceuticals, INC. | $26.13 | 2022-2023 | Qelbree |
| Medtronic, INC. | $22.25 | 2023 | Intellis Adaptivestim |
| Jazz Pharmaceuticals INC. | $20.33 | 2022 | |
| Tolmar, INC. | $16.97 | 2024 | |
| Sanofi Pasteur INC. | $16.75 | 2019 | |
| Adlon Therapeutics L.P. | $16.10 | 2020 | |
| Sk Life Science, INC. | $16.04 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $13.03 | 2020 | |
| Inogen, INC. | $12.57 | 2022 | |
| Phathom Pharmaceuticals, INC. | $10.78 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randall Hall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.